Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 337 to 339 of 339 entries
Sorted by: Best Match Show Resources per page
LC-MS Characterization and Biological Activities of Cuban Cultivars of .

Plants (Basel, Switzerland)

Rodríguez-Ferreiro AO, Ochoa-Pacheco A, Méndez-Rodriguez D, Ortiz-Beatón E, Font-Salmo O, Guisado-Bourzac F, Molina-Bertrán S, Monzote L, Cos P, Foubert K, Pieters L, Perez-Novo C, Vanden Berghe W, Escalona-Arranz JC, Setzer WN.
PMID: 35009137
Plants (Basel). 2022 Jan 04;11(1). doi: 10.3390/plants11010134.

No abstract available.

Cite
Rodríguez-Ferreiro AO, Ochoa-Pacheco A, Méndez-Rodriguez D, et al. LC-MS Characterization and Biological Activities of Cuban Cultivars of . Plants (Basel). 2022;11(1)doi: 10.3390/plants11010134.
Rodríguez-Ferreiro, A. O., Ochoa-Pacheco, A., Méndez-Rodriguez, D., Ortiz-Beatón, E., Font-Salmo, O., Guisado-Bourzac, F., Molina-Bertrán, S., Monzote, L., Cos, P., Foubert, K., Pieters, L., Perez-Novo, C., Vanden Berghe, W., Escalona-Arranz, J. C., & Setzer, W. N. (2022). LC-MS Characterization and Biological Activities of Cuban Cultivars of . Plants (Basel, Switzerland), 11(1), . https://doi.org/10.3390/plants11010134
Rodríguez-Ferreiro, Annarli O, et al. "LC-MS Characterization and Biological Activities of Cuban Cultivars of ." Plants (Basel, Switzerland) vol. 11,1 (2022). doi: https://doi.org/10.3390/plants11010134
Rodríguez-Ferreiro AO, Ochoa-Pacheco A, Méndez-Rodriguez D, Ortiz-Beatón E, Font-Salmo O, Guisado-Bourzac F, Molina-Bertrán S, Monzote L, Cos P, Foubert K, Pieters L, Perez-Novo C, Vanden Berghe W, Escalona-Arranz JC, Setzer WN. LC-MS Characterization and Biological Activities of Cuban Cultivars of . Plants (Basel). 2022 Jan 04;11(1). doi: 10.3390/plants11010134. PMID: 35009137.
Copy Download .nbib Format: NLM
Canine Lafora Disease: An Unstable Repeat Expansion Disorder.

Life (Basel, Switzerland)

von Klopmann T, Ahonen S, Espadas-Santiuste I, Matiasek K, Sanchez-Masian D, Rupp S, Vandenberghe H, Rose J, Wang T, Wang P, Minassian BA, Rusbridge C.
PMID: 34357061
Life (Basel). 2021 Jul 14;11(7). doi: 10.3390/life11070689.

Canine Lafora disease is a recessively inherited, rapidly progressing neurodegenerative disease caused by the accumulation of abnormally constructed insoluble glycogen Lafora bodies in the brain and other tissues due to the loss of NHL repeat containing E3 ubiquitin protein...

Cite
von Klopmann T, Ahonen S, Espadas-Santiuste I, et al. Canine Lafora Disease: An Unstable Repeat Expansion Disorder. Life (Basel). 2021;11(7)doi: 10.3390/life11070689.
von Klopmann, T., Ahonen, S., Espadas-Santiuste, I., Matiasek, K., Sanchez-Masian, D., Rupp, S., Vandenberghe, H., Rose, J., Wang, T., Wang, P., Minassian, B. A., & Rusbridge, C. (2021). Canine Lafora Disease: An Unstable Repeat Expansion Disorder. Life (Basel, Switzerland), 11(7), . https://doi.org/10.3390/life11070689
von Klopmann, Thilo, et al. "Canine Lafora Disease: An Unstable Repeat Expansion Disorder." Life (Basel, Switzerland) vol. 11,7 (2021). doi: https://doi.org/10.3390/life11070689
von Klopmann T, Ahonen S, Espadas-Santiuste I, Matiasek K, Sanchez-Masian D, Rupp S, Vandenberghe H, Rose J, Wang T, Wang P, Minassian BA, Rusbridge C. Canine Lafora Disease: An Unstable Repeat Expansion Disorder. Life (Basel). 2021 Jul 14;11(7). doi: 10.3390/life11070689. PMID: 34357061; PMCID: PMC8304204.
Copy Download .nbib Format: NLM
ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia.

Molecular therapy. Methods & clinical development

Ilyinskii PO, Michaud AM, Rizzo GL, Roy CJ, Leung SS, Elkins SL, Capela T, Chowdhury A, Li L, Chandler RJ, Manoli I, Andres-Mateos E, Johnston LPM, Vandenberghe LH, Venditti CP, Kishimoto TK.
PMID: 34485611
Mol Ther Methods Clin Dev. 2021 Jul 16;22:279-292. doi: 10.1016/j.omtm.2021.06.015. eCollection 2021 Sep 10.

A major barrier to adeno-associated virus (AAV) gene therapy is the inability to re-dose patients due to formation of vector-induced neutralizing antibodies (Nabs). Tolerogenic nanoparticles encapsulating rapamycin (ImmTOR) provide long-term and specific suppression of adaptive immune responses, allowing for...

Cite
Ilyinskii PO, Michaud AM, Rizzo GL, et al. ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia. Mol Ther Methods Clin Dev. 2021;22:279-292doi: 10.1016/j.omtm.2021.06.015.
Ilyinskii, P. O., Michaud, A. M., Rizzo, G. L., Roy, C. J., Leung, S. S., Elkins, S. L., Capela, T., Chowdhury, A., Li, L., Chandler, R. J., Manoli, I., Andres-Mateos, E., Johnston, L. P. M., Vandenberghe, L. H., Venditti, C. P., & Kishimoto, T. K. (2021). ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia. Molecular therapy. Methods & clinical development, 22279-292. https://doi.org/10.1016/j.omtm.2021.06.015
Ilyinskii, Petr O, et al. "ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia." Molecular therapy. Methods & clinical development vol. 22 (2021): 279-292. doi: https://doi.org/10.1016/j.omtm.2021.06.015
Ilyinskii PO, Michaud AM, Rizzo GL, Roy CJ, Leung SS, Elkins SL, Capela T, Chowdhury A, Li L, Chandler RJ, Manoli I, Andres-Mateos E, Johnston LPM, Vandenberghe LH, Venditti CP, Kishimoto TK. ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia. Mol Ther Methods Clin Dev. 2021 Jul 16;22:279-292. doi: 10.1016/j.omtm.2021.06.015. eCollection 2021 Sep 10. PMID: 34485611; PMCID: PMC8399083.
Copy Download .nbib Format: NLM
Showing 337 to 339 of 339 entries